|
MX2017002979A
|
|
Ofloxacin and ornidazole pharmaceutical compositions.
|
|
WO2017115329A1
|
|
C-3 novel triterpenone derivatives as hiv inhibitors
|
|
WO2017025899A1
|
|
Novel c28-amides with c3-modifications of triterpene derivatives as hiv inhibitors
|
|
WO2017025901A1
|
|
Novel c28-analogues with c3-modifications of triterpene derivatives as hiv inhibitors
|
|
WO2017021922A1
|
|
Novel substituted amides of triterpene derivatives as hiv inhibitors
|
|
WO2017017630A1
|
|
Novel betulinic substituted amide derivatives as hiv inhibitors
|
|
US2017020880A1
|
|
Pharmaceutical compositions of trametinib
|
|
WO2016199049A1
|
|
Process for the preparation of ledipasvir
|
|
WO2016147099A2
|
|
C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors
|
|
KR20170110143A
|
|
C-3 New Tritterpenone with C-17 Reverse Amide Derivatives as HIV Inhibitors
|
|
EP3215490A1
|
|
Process for the preparation of lomitapide
|
|
WO2016035018A1
|
|
Crystalline form of eltrombopag free acid
|
|
US2017129916A1
|
|
Novel betulinic proline imidazole derivatives as hiv inhibitors
|
|
WO2015198263A2
|
|
Novel betulinic proline substituted derivatives as hiv inhibitors
|
|
US2017119678A1
|
|
Extended release compositions of carvedilol phosphate
|
|
WO2015125152A2
|
|
Pharmaceutical compositions of asenapine
|
|
US2017057917A1
|
|
Polymorphs of lomitapide and its salts
|
|
WO2015104720A2
|
|
Parenteral compositions of bendamustine
|
|
WO2015092813A2
|
|
Lyophilized compositions comprising isomalt
|
|
WO2015049698A2
|
|
Process for regorafenib
|
